• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吴茱萸次碱通过诱导CYP1A2加重对乙酰氨基酚诱导的急性肝损伤。

Rutaecarpine Aggravates Acetaminophen-Induced Acute Liver Injury by Inducing CYP1A2.

作者信息

Wan Meiqi, Gao Hua, Liu Xiaoyan, Zhang Youbo

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, Key Laboratory of State Administration of Traditional Chinese Medicine for Compatibility Toxicology, Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Toxics. 2024 Jul 18;12(7):515. doi: 10.3390/toxics12070515.

DOI:10.3390/toxics12070515
PMID:39058167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11280960/
Abstract

In this study, we investigated whether rutaecarpine could aggravate acetaminophen-induced acute liver damage in vivo and in vitro. CCK-8 and apoptosis assays were performed to verify the cytotoxicity of acetaminophen to L02 cells with or without rutaecarpine. The expression levels of the target proteins and genes were determined using Western blotting and qRT-PCR. The liver pathological changes were evaluated with hematoxylin and eosin staining, while the aspartate aminotransferase (AST) and alanine aminotransferase (AST) levels in plasma were measured to assess the liver damage. Our results revealed that pretreatment of the cell and mice with rutaecarpine significantly aggravated the acetaminophen-induced liver damage. Mechanistically, rutaecarpine induces the CYP1A2 protein, which accelerates the metabolism of acetaminophen to produce a toxic intermediate, N-acetyl-p-benzoquinone imine (NAPQI), leading to severe liver inflammation. Rutaecarpine exacerbated the liver damage by upregulating CYP1A2 and proinflammatory factors. These findings highlight the importance of carefully considering the dosage of rutaecarpine when combined with acetaminophen in drug design and preclinical trials.

摘要

在本研究中,我们调查了吴茱萸次碱是否会在体内和体外加重对乙酰氨基酚诱导的急性肝损伤。进行CCK-8和凋亡检测,以验证对乙酰氨基酚在有或没有吴茱萸次碱的情况下对L02细胞的细胞毒性。使用蛋白质免疫印迹法和qRT-PCR测定靶蛋白和基因的表达水平。用苏木精和伊红染色评估肝脏病理变化,同时测量血浆中天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)水平以评估肝损伤。我们的结果显示,用吴茱萸次碱预处理细胞和小鼠会显著加重对乙酰氨基酚诱导的肝损伤。机制上,吴茱萸次碱诱导CYP1A2蛋白,加速对乙酰氨基酚的代谢以产生有毒中间体N-乙酰对苯醌亚胺(NAPQI),导致严重的肝脏炎症。吴茱萸次碱通过上调CYP1A2和促炎因子加重肝损伤。这些发现凸显了在药物设计和临床试验中将吴茱萸次碱与对乙酰氨基酚联合使用时仔细考虑其剂量的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/defe6b77f98d/toxics-12-00515-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/d0ef6373659b/toxics-12-00515-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/66daa4b974d4/toxics-12-00515-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/f667935ac646/toxics-12-00515-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/defe6b77f98d/toxics-12-00515-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/d0ef6373659b/toxics-12-00515-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/66daa4b974d4/toxics-12-00515-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/f667935ac646/toxics-12-00515-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b54/11280960/defe6b77f98d/toxics-12-00515-g004.jpg

相似文献

1
Rutaecarpine Aggravates Acetaminophen-Induced Acute Liver Injury by Inducing CYP1A2.吴茱萸次碱通过诱导CYP1A2加重对乙酰氨基酚诱导的急性肝损伤。
Toxics. 2024 Jul 18;12(7):515. doi: 10.3390/toxics12070515.
2
Rutaecarpine Protects against Acetaminophen-Induced Acute Liver Injury in Mice by Activating Antioxidant Enzymes.吴茱萸次碱通过激活抗氧化酶对乙酰氨基酚诱导的小鼠急性肝损伤起到保护作用。
Antioxidants (Basel). 2021 Jan 10;10(1):86. doi: 10.3390/antiox10010086.
3
Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice.细胞色素P450 1A2(CYP1A2)在对乙酰氨基酚肝毒性中的作用:利用Cyp1a2基因敲除小鼠进行的研究
Toxicol Appl Pharmacol. 1998 Nov;153(1):102-8. doi: 10.1006/taap.1998.8543.
4
Acetaminophen-induced reduction of NIMA-related kinase 7 expression exacerbates acute liver injury.对乙酰氨基酚诱导的NIMA相关激酶7表达降低会加剧急性肝损伤。
JHEP Rep. 2022 Jul 20;4(10):100545. doi: 10.1016/j.jhepr.2022.100545. eCollection 2022 Oct.
5
Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.CYP1A2和CYP2E1双基因敲除小鼠对乙酰氨基酚毒性的保护作用。
Toxicol Appl Pharmacol. 1998 Sep;152(1):193-9. doi: 10.1006/taap.1998.8501.
6
2,3,4',5-tetrahydroxystilbene-2-O-β-D-glucoside exacerbates acetaminophen-induced hepatotoxicity by inducing hepatic expression of CYP2E1, CYP3A4 and CYP1A2.2,3,4',5-四羟基二苯乙烯-2-O-β-D-葡萄糖苷通过诱导肝 CYP2E1、CYP3A4 和 CYP1A2 的表达加剧对乙酰氨基酚诱导的肝毒性。
Sci Rep. 2017 Nov 28;7(1):16511. doi: 10.1038/s41598-017-16688-5.
7
Galangin Nanoparticles Protect Acetaminophen-Induced Liver Injury: A Biochemical and Histopathological Approach.高良姜素纳米颗粒对乙酰氨基酚诱导的肝损伤的保护作用:生化与组织病理学研究方法
Evid Based Complement Alternat Med. 2022 Aug 10;2022:4619064. doi: 10.1155/2022/4619064. eCollection 2022.
8
CHOP is a critical regulator of acetaminophen-induced hepatotoxicity.CHOP 是对乙酰氨基酚诱导的肝毒性的关键调节因子。
J Hepatol. 2013 Sep;59(3):495-503. doi: 10.1016/j.jhep.2013.04.024. Epub 2013 May 9.
9
Corilagin alleviates acetaminophen-induced hepatotoxicity via enhancing the AMPK/GSK3β-Nrf2 signaling pathway.鞣花酸通过增强 AMPK/GSK3β-Nrf2 信号通路缓解对乙酰氨基酚诱导的肝毒性。
Cell Commun Signal. 2019 Jan 10;17(1):2. doi: 10.1186/s12964-018-0314-2.
10
Isatidis Folium alleviates acetaminophen-induced liver injury in mice by enhancing the endogenous antioxidant system.大青叶通过增强内源性抗氧化系统减轻对乙酰氨基酚诱导的小鼠肝损伤。
Environ Toxicol. 2020 Nov;35(11):1251-1259. doi: 10.1002/tox.22990. Epub 2020 Jul 17.

本文引用的文献

1
Hepatotoxicity Comparison of Crude and Licorice-Processed Euodiae Fructus in Rats With Stomach Excess-Cold Syndrome.吴茱萸生品与甘草制吴茱萸对寒邪犯胃证大鼠肝毒性的比较
Front Pharmacol. 2021 Nov 23;12:756276. doi: 10.3389/fphar.2021.756276. eCollection 2021.
2
Clinical and Molecular Perspectives on Inflammation-Mediated Regulation of Drug Metabolism and Transport.炎症介导的药物代谢和转运调节的临床和分子观点。
Clin Pharmacol Ther. 2022 Aug;112(2):277-290. doi: 10.1002/cpt.2432. Epub 2021 Oct 27.
3
Rutaecarpine Protects against Acetaminophen-Induced Acute Liver Injury in Mice by Activating Antioxidant Enzymes.
吴茱萸次碱通过激活抗氧化酶对乙酰氨基酚诱导的小鼠急性肝损伤起到保护作用。
Antioxidants (Basel). 2021 Jan 10;10(1):86. doi: 10.3390/antiox10010086.
4
Cytochrome P450 Mediated Bioactivation of Rutaevin, a Bioactive and Potentially Hepatotoxic Component of .细胞色素 P450 介导的生物活化 RutaeVin,一种生物活性和潜在肝毒性的成分。
Chem Res Toxicol. 2020 Dec 21;33(12):3054-3064. doi: 10.1021/acs.chemrestox.0c00475. Epub 2020 Dec 11.
5
CYP3A4 inducer aggravates big flower Evodiae Fructus-induced hepatotoxicity whereas limonin attenuates its hepatotoxicity.CYP3A4 诱导剂加重了大花吴茱萸引起的肝毒性,而柠檬苦素则减轻了其肝毒性。
J Ethnopharmacol. 2021 Jan 10;264:113277. doi: 10.1016/j.jep.2020.113277. Epub 2020 Aug 15.
6
Effect of CYP3A inducer/inhibitor on pharmacokinetics of five alkaloids in Evodiae Fructus.CYP3A 诱导剂/抑制剂对吴茱萸中 5 种生物碱药代动力学的影响。
Chem Biol Interact. 2020 Aug 25;327:109146. doi: 10.1016/j.cbi.2020.109146. Epub 2020 Jun 17.
7
EASL Clinical Practice Guidelines: Drug-induced liver injury.EASL 临床实践指南:药物性肝损伤。
J Hepatol. 2019 Jun;70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27.
8
Glycycoumarin protects mice against acetaminophen-induced liver injury predominantly via activating sustained autophagy.甘草香豆素主要通过激活持续自噬来保护小鼠免受对乙酰氨基酚诱导的肝损伤。
Br J Pharmacol. 2018 Oct;175(19):3747-3757. doi: 10.1111/bph.14444. Epub 2018 Aug 21.
9
Structure-Activity Relationships of the Main Bioactive Constituents of on Aryl Hydrocarbon Receptor Activation and Associated Bile Acid Homeostasis.对芳基烃受体激活和相关胆汁酸动态平衡的主要生物活性成分的结构-活性关系的研究。
Drug Metab Dispos. 2018 Jul;46(7):1030-1040. doi: 10.1124/dmd.117.080176. Epub 2018 Apr 24.
10
Licochalcone A Upregulates Nrf2 Antioxidant Pathway and Thereby Alleviates Acetaminophen-Induced Hepatotoxicity.甘草查尔酮A上调Nrf2抗氧化途径,从而减轻对乙酰氨基酚诱导的肝毒性。
Front Pharmacol. 2018 Mar 23;9:147. doi: 10.3389/fphar.2018.00147. eCollection 2018.